News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Ansell.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work
News
Short & Caught: Short sellers still queuing for volatile FLT?
News
Trading Places: Gold stocks in demand as volatility continues and FY22 draws to a close
News
The Ethical Investor: Tackling modern slavery in the supply chain with Misio’s co-founder Jeremy Biggs
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
News
ASX Large Caps: Energy plunges as investors take profit, Tech mounts comeback
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Experts
ScoPo’s Powerplays: Who’s making a gritty comeback?
News
ASX Large Caps: Tech stocks surge but Ansell tumbles 13pc on earnings downgrade
Health & Biotech
ScoPo’s Powerplays: COVID surge to drive up value in these two ASX health stocks
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
News
Closing Bell: Energy shares push ASX higher
News
Quarterlies Top 5: Here’s another online market place that’s rising today
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
News